The oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens for the biopharma industry, has committed to an initial tranche of projects for 2020 with an aggregate value of £250,000 with its long-standing customer Merck KGaA. These projects are expected to be completed during the first six to eight months of the next calendar year and will span a range of drug targets and treatment types in both pre-c
20 Dec 2019
£250k projects to be delivered for Merck
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
£250k projects to be delivered for Merck
Physiomics Plc (PYC:LON) | 1.3 0 13.0% | Mkt Cap: 1.76m
- Published:
20 Dec 2019 -
Author:
Derren Nathan -
Pages:
6
The oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens for the biopharma industry, has committed to an initial tranche of projects for 2020 with an aggregate value of £250,000 with its long-standing customer Merck KGaA. These projects are expected to be completed during the first six to eight months of the next calendar year and will span a range of drug targets and treatment types in both pre-c